Monday, July 24, 2017 6:14:13 PM
The Financial Newsweek analysis clearly indicates what many of us already know: $VGID is oversold, undervalued, and a trend reversal is underway! Looking forward to the financials when tallied, updates, and the promised conference call.
I'm excited, it's looking real good to me and with improved financials quarter-over-quarter again, and just a little guidance going forward, okay maybe a lot of guidance with so many projects in the works, $VGID is very likely going to test recent 52 week highs.
Go $VGID, Go Buzzy!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM